Research & Development

R & D strategy
60% is the key intermediate that can be forecasted market value of clinical or close to clinical.
20% is the products that have good market prospects and suit the industry technology .
20% is the products that cooperated with large-scale pharmaceutical enterprises and used in clinical new drugs devolopment.
R & D institutions
The company sets up a special research center for product research and development work.
There are a contingent of high-quality expert consultants and a group of experienced researchers in Research Center, with the close cooperation with research institutions ,the company can capture the global drug product information and technology timely, promoting the industrialization of scientific research process.
Rely on strong research and development capability, we attach great importance to R & D feasibility of the production process, in the process of research and development process. In the view of service, the company can provide g-class companies, kilograms, tonnage-class products to the custom synthesis services, and can test products in the enlarged, technology transfer and commercialization of production rapid, save time and cost for customers.
We look every customer’s requirement as executive instruction, according to the different projects or the different devolopment progress of projects, we have dedicated project managers communicate with customers.